James P. Shaffer

2011

In 2011, James P. Shaffer earned a total compensation of $1.2M as Vice President and Chief Commercial Officer at Halozyme Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$35,000
Option Awards$982,940
Salary$120,705
Other$16,180
Total$1,154,825

Shaffer received $982.9K in option awards, accounting for 85% of the total pay in 2011.

Shaffer also received $35K in non-equity incentive plan, $120.7K in salary and $16.2K in other compensation.

Rankings

In 2011, James P. Shaffer's compensation ranked 5,133rd out of 10,747 executives tracked by ExecPay. In other words, Shaffer earned more than 52.2% of executives.

ClassificationRankingPercentile
All
5,133
out of 10,747
52nd
Division
Manufacturing
1,856
out of 3,960
53rd
Major group
Chemicals And Allied Products
395
out of 1,033
62nd
Industry group
Drugs
244
out of 781
69th
Industry
Biological Products, Except Diagnostic Substances
40
out of 157
75th
Source: SEC filing on April 7, 2014.

Shaffer's colleagues

We found six more compensation records of executives who worked with James P. Shaffer at Halozyme Therapeutics in 2011.

2011

Jean Liu

Halozyme Therapeutics

General Counsel

2011

Kurt Gustafson

Halozyme Therapeutics

Chief Financial Officer

2011

William Fallon

Halozyme Therapeutics

Vice President, Manufacturing & Operations

2011

H Shepard

Halozyme Therapeutics

Chief Scientific Officer

2011

Gregory Frost

Halozyme Therapeutics

Chief Executive Officer

2011

David Ramsay

Halozyme Therapeutics

Chief Financial Officer

In-depth

You may also like